CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 820 enrolled
Drug / intervention
Buprenorphine-Naloxone +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03026790
NCT03026790Phase 2Completed

Comparative Effectiveness of Patient-Centered Strategies to Improve Pain Management and Opioid Safety for Veterans

University of Minnesota·interventional·Posted Jan 20, 2017·Updated Jun 5, 2023

In Brief

A Phase 2 clinical trial evaluating Medication management, Non-pharmacological pain management, and 1 other intervention for Chronic Pain. Completed, enrolled 820 participants across 1 site.

Detailed Summary

Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 20, 2017
Enrollment StartOct 19, 2017
Primary CompletionMar 17, 2022
Study CompletionOct 30, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 9.5 years ago

Interventions

Medication managementother

Individualized management of medications for pain

Non-pharmacological pain managementother

Individualized management of non-medication pain treatment approaches

Buprenorphine-Naloxonedrug

Option of using buprenorphine-naloxone to assist with opioid dose reduction or discontinuation